The disparity between exoASO-STAT6 and free ASO is pronounced, evidenced by the significant tumor growth inhibition elicited by exoASO-STAT6, in contrast to the inactivity of free ASO at an equivalent dosage. The gene discussed is STAT6; the disease is neoplasm.